Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation

Dos Santos David M. Cordas; Saliba Rima M.; Patel Romil; Bashir Qaiser; Hosing Chitra; Kebriaei Partow; Khouri Issa F.; Nieto Yago; Popat Uday; Lee Hans C.; Manasanch Elisabet E.; Patel Krina K.; Thomas Sheeba K.; Weber Donna M.; Orlowski Robert Z.; Champlin Richard E.; Qazilbash Muzaffar H.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation

【24h】

Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation

机译：年龄作为经历前期自体造血干细胞移植的多发性骨髓瘤患者整体存活的预后因素

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共4页
作者
Dos Santos David M. Cordas; Saliba Rima M.; Patel Romil; Bashir Qaiser; Hosing Chitra; Kebriaei Partow; Khouri Issa F.; Nieto Yago; Popat Uday; Lee Hans C.; Manasanch Elisabet E.; Patel Krina K.; Thomas Sheeba K.; Weber Donna M.; Orlowski Robert Z.; Champlin Richard E.; Qazilbash Muzaffar H.;
展开▼
作者单位

Univ Texas MD Anderson Canc Ctr Dept Stem Cell Transplantat &

Cellular Therapy Houston TX 77030;

MD Anderson Canc Ctr Dept Stem Cell Transplantat &

Cellular Therapy Houston TX USA;

Univ Texas MD Anderson Canc Ctr Dept Stem Cell Transplantat &

Cellular Therapy Houston TX 77030;

Univ Texas MD Anderson Canc Ctr Dept Stem Cell Transplantat &

Cellular Therapy Houston TX 77030;

Univ Texas MD Anderson Canc Ctr Dept Stem Cell Transplantat &

Cellular Therapy Houston TX 77030;

Univ Texas MD Anderson Canc Ctr Dept Stem Cell Transplantat &

Cellular Therapy Houston TX 77030;

Univ Texas MD Anderson Canc Ctr Dept Stem Cell Transplantat &

Cellular Therapy Houston TX 77030;

Univ Texas MD Anderson Canc Ctr Dept Stem Cell Transplantat &

Cellular Therapy Houston TX 77030;

Univ Texas MD Anderson Canc Ctr Dept Stem Cell Transplantat &

Cellular Therapy Houston TX 77030;

Univ Texas MD Anderson Canc Ctr Dept Lymphoma &

Myeloma Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Lymphoma &

Myeloma Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Lymphoma &

Myeloma Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Lymphoma &

Myeloma Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Stem Cell Transplantat &

Cellular Therapy Houston TX 77030;

Univ Texas MD Anderson Canc Ctr Dept Stem Cell Transplantat &

Cellular Therapy Houston TX 77030;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation [J] . Dos Santos David M. Cordas, Saliba Rima M., Patel Romil, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2020,第6期

机译：年龄是多发性骨髓瘤患者整体存活的预后因素，其接受前期自体造血干细胞移植
2. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. [J] . Kim JS, Kim K, Cheong JW, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2009,第4期

机译：自体干细胞移植前完全缓解状态是多发性骨髓瘤患者接受前期单次自体移植的重要预后因素。
3. Younger donor’s age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Fran?aise de Greffe de Moell… | Haematologica [J] . Claire Fabre, Serge Koscielny, Mohamad Mohty, Haematologica . 2012,第4期

机译：较年轻的供者的年龄和前期串联是通过串联自体-异源性干细胞移植治疗的多发性骨髓瘤患者生存的两个独立的预后因素：法国社会科学研究院的回顾性研究…|血液学
4. HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS (AL): AN ABMTR STUDY [C] . DH Vesole, W Perez, D Reece, International Symposium on Amyloidosis . 2005

机译：具有自体造血干细胞移植（HSCT）的高剂量治疗用于初级全身淀粉样蛋白症（AL）的患者：ABMTR研究
5. Dyadic predictors of psychosocial distress in patients undergoing autologous hematopoietic stem cell transplant (HSCT). [D] . Geller, Jessica B. 2016

机译：自体造血干细胞移植（HSCT）患者心理社会困扰的二元预测因子。
6. Younger donor’s age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) [O] . Claire Fabre, Serge Koscielny, Mohamad Mohty, 2012

机译：较年轻的供体的年龄和前期串联是通过串联自体-异源性干细胞移植治疗的多发性骨髓瘤患者生存的两个独立的预后因素：法国社会科学基金会的回顾性研究（SFGM-TC）
7. Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation [O] . David M. Cordas dos Santos, Rima M. Saliba, Romil Patel, 2020

机译：年龄是多发性骨髓瘤患者整体存活的预后因素，经历前期自体造血干细胞移植

Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation

著录项

引文网络

相似文献

相关主题

期刊订阅